BNP (B-type Natriuretic Peptide) vs Hexarelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

BNP (B-type Natriuretic Peptide)

BNP is a cardiac neurohormone released primarily by ventricles in response to volume/pressure overload. It's a major biomarker for heart failure and has therapeutic applications as nesiritide.

Full details →

Hexarelin

Hexarelin is a potent synthetic hexapeptide growth hormone secretagogue. It provides the strongest GH release among GHRPs but is associated with rapid desensitization of receptors.

Full details →

Side-by-Side Comparison

Aspect	BNP (B-type Natriuretic Peptide)	Hexarelin
Dose Range	25 mcg–100 mcg	100 mcg–300 mcg
Frequency	1x daily	2x daily
Cycle Length	1–4 weeks	8–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	Similar to ANP - activates NPR-A receptors to produce vasodilation, natriuresis, and RAAS suppression. Released in response to ventricular wall stress.	Acts as a ghrelin mimetic with high potency at the GHS receptor. Provides powerful GH release but receptor desensitization occurs faster than with other GHRPs, requiring cycling.
Typical Dosage	Nesiritide (recombinant BNP): 2mcg/kg IV bolus followed by 0.01mcg/kg/min continuous infusion for acute decompensated heart failure.	Typical dosing: 100-200mcg administered 2-3 times daily for 4-6 weeks, followed by an equal off period to allow receptor resensitization.
Administration	Intravenous administration only. Used in acute care settings for heart failure. BNP levels also used diagnostically.	Subcutaneous injection. Cycling is essential to maintain effectiveness. Often used in short bursts rather than continuous protocols.
Side Effects	Hypotension (common and dose-limiting), headache, nausea, and potential renal function worsening in some patients.	Water retention, cortisol and prolactin increase, hunger (moderate), tingling, and potential blood pressure effects.
Best For	Recovery & Healing	Muscle Growth Recovery & Healing